LGC’s COVID-19 response

News (ZH) - LGC, an international leader in the life sciences tools sector, is playing an active role in the global response to COVID-19

LGC's innovative SARS-CoV-2 Quality Solutions now includes S gene

News (ZH) - Offers expanded genome coverage to include S gene region

COVID-19: How the National Measurement Laboratory supports standards to fight COVID19

博客 - This World Metrology Day, the National Measurement Laboratory at LGC celebrates the work of our metrologists during the current COVID-19 pandemic.

LGC expands SARS-CoV-2 offering to include serology quality solutions

News (ZH) - Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence

NML at LGC joins more than 500 scientists in 18 countries to map COVID-19 effects and treatments in patients’ blood

News (ZH) - Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement

LGC expands SARS-CoV-2 serology offering with 11-member positive-patient Performance Panel

News (ZH) - Panel demonstrates a range of SARS-CoV-2 antibody reactivity

COVID-19 recovery trials: Dexamethasone and standardisation

博客 - Dexamethasone has undergone study by a team of scientists at Oxford University as part of their Recovery trial.

New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes

News (ZH) - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS

The importance of standardisation of diagnostic measurements in the COVID-19 pandemic

博客 - Dr Jim Huggett, Principal Scientist at the NML at LGC, recently answered some of our questions around why standardised measurement is so important to medicine.

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News (ZH) - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma